Global Epilepsy Surgery Market By Procedure (Resective Surgery, Laser Interstitial Thermal Therapy (LITT), Deep Brain Stimulation), By End-User (Hospitals & Clinics, Specialty Centers), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031

Epilepsy surgery is a procedure to remove the seizure-inducing area of the brain or to limit the spread of seizure activity. The type of surgery performed depends on the type of seizures and where they begin in the brain. Epilepsy surgery is most effective when seizures always occur out of a single location in the brain.

Epilepsy surgery is not the first line of treatment but is considered when at least two anti-seizure medications have failed to control an individual’s seizures. This surgery is an option when medication fails to control seizures, a condition known as medically refractory epilepsy or drug-resistant epilepsy. The goal of epilepsy surgery is to stop seizures or limit their severity with or without the use of medication.

Poorly controlled epilepsy can result in several complications and health risks such as developmental delays in children, the worsening of memory or other cognitive skills, depression and anxiety, etc.

Segmentation of Global Epilepsy Surgery Market

By Procedure Type

• Resective Surgery
• Laser Interstitial Thermal Therapy (LITT)
• Deep Brain Stimulation
• Other Procedure Types

By End-User

• Hospitals & Clinics
• Specialty Centers
• Other End-Users

By Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Market Dynamics

The global epilepsy surgery market is expected to register increased revenue growth due to a spike in the number of cases of brain injuries due to road accidents, the increasing prevalence of epilepsy, as well as the demand for necessary surgical procedures. Furthermore, advancements in robot-assisted surgery and its greater adoption levels may be attributed to efficient and accurate surgical planning & navigation, which in turn, is likely to drive market expansion opportunities in the process.

Emerging markets are anticipated to offer potential growth opportunities for global industry players due to technological advancements, booming geriatric populations that are more prone to seizure disorders, as well as the rolling-out of respective government initiatives towards the undertaking of research studies that are focused on epilepsy surgery.

However, the COVID-19 pandemic has impacted the delivery of care to People with Epilepsy (PWE) in numerous ways, including limitations on in-person contact as well as restrictions in carrying out neurophysiological procedures.

Competitive Landscape

• Stryker Corporation
• Zimmer Biomet Holdings Inc.
• Auris Health Inc. (Hansen Medical Inc.)
• Intuitive Surgical Inc.
• Medtronic Plc
• Cephalon Inc.
• CMR Surgical
• Natus Medical Incorporated
• Livanova Plc
• Other Key Players

Recent Developments in this Industry:

• Zimmer Biomet has acquired the rights to distribute NeuroOne’s Evo electrodes, which are used in brain surgeries related to the treatment of epilepsy.
• Medtronic receives FDA approval for Deep Brain Stimulation Therapy for Medically Refractory Epilepsy.
• Medtronic Launches Deep Brain Stimulation for Medically-Refractory Epilepsy.
• Natus Medical Incorporated has successfully performed a clinical case using Natus’ newly launched XactTrode™ family of platinum subdural electrodes.

For the Epilepsy Surgery Market research study, the following years have been considered to estimate the market size: